Page last updated: 2024-08-25

nobiletin and Prostatic Neoplasms, Castration-Resistant

nobiletin has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Deng, Y; He, X; Hu, T; Huang, H; Kong, W; Liao, Y; Liu, Y; Shao, Z; Sun, W; Xia, X; Yu, C1

Other Studies

1 other study(ies) available for nobiletin and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Selective degradation of AR-V7 to overcome castration resistance of prostate cancer.
    Cell death & disease, 2021, 09-21, Volume: 12, Issue:10

    Topics: Animals; Benzamides; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Flavones; Humans; Lysine; Male; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Proteasome Endopeptidase Complex; Proteolysis; Receptors, Androgen; Ubiquitin Thiolesterase; Ubiquitination

2021